Literature DB >> 24530935

National Immunization Commission: strengthening evidence-based decision making in Argentina.

Daniel Stecher1, Alejandra Gaiano2, Cristián Biscayart2, Angela Gentile3, Silvia Gonzalez Ayala4, Eduardo López4, Pablo Bonvehí5, Pablo Yedlin6, Cara Janusz7, Carla Vizzotti2.   

Abstract

In Argentina, the National Technical Advisory Group on Immunizations is represented by the National Immunization Commission (CoNaIn), an organization created by the Ministry of Health in 2000. Recently, the Argentine government has decided to prioritize vaccination as a state policy, emphasizing this strategy as a sign of social equity so CoNaIn was restructured to increase its capacity to formulate sound and evidence-based recommendations. The commission shall consist of a group of immunization experts, representatives of scientific societies, the immunization program and the Ministry of Health. Its functions include the formulation of recommendations on the introduction of vaccines into the immunization program. The recommendations are based on technical, programmatic and social criteria. This decision-making process transparent with the support and advice of experts and scientific societies and guided by available evidence decisions help strengthen the Ministry of Health immunization policy generating greater confidence and support from the population and health professionals.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Decision making; Evidence based decisions; Immunization; National advisory committee

Mesh:

Year:  2014        PMID: 24530935     DOI: 10.1016/j.vaccine.2014.01.080

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  Moroccan National Immunization Technical Advisory Group: a valuable asset for the national immunization program and the immunization agenda in the EMRO region.

Authors:  Imane Jroundi; Mohammed Benazzouz; Abdel Hakim Yahyane; Moulay Tahar Alaoui; Nathalie El Omeiri
Journal:  Hum Vaccin Immunother       Date:  2021-05-14       Impact factor: 3.452

2.  Hepatitis B vaccine adverse events in China: risk control and regulation.

Authors:  Li Meina; Liu Xiaodong; Zhang Lulu
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.